Serum Sclerostin in Hepatitis C Virus Infected Patients

BACKGROUND: Sclerostin inhibits osteoblast functions, differentiations, and survival rates. As an endogenous inhibitor of the Wnt/β-catenin pathway, the sclerostin should be related to decreased bone masses, although several studies indicate opposite results. In addition, it may be related to insuli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: González-Reimers, Emilio, López-Prieto, Javier, Pelazas-González, Ricardo, Alemán-Valls, M.Remedios, José de la Vega-Prieto, María, Jorge-Ripper, Carlos, Durán-Castellón, M. Carmen, Santolaria-Fernández, F
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Society for Bone and Mineral Research 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3970296/
https://ncbi.nlm.nih.gov/pubmed/24707469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11005/jbm.2014.21.1.69
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados